AKT1 and hepatocellular carcinoma: Our present study found PIK3C2α is a new target of miR-26a, and miR-26a inhibited HCC angiogenesis mainly through suppressing the PIK3C2α/p-Akt/HIF-1α/VEGFA pathway.